Objective: Clinicopathological analysis of testicular tumors as per World Health Organisation (WHO) classification.
INTRODUCTION
Cancers of the testes is the second most frequent male genital cancer. The worldwide incidence of testicular cancer has doubled over the last 40 years. In most countries, testicular cancer is rare, with an age-standardized incidence rate ranging from about 1/100,000 in Asian, African/African-American populations to 9.2/100,000 in Denmark). In Indian population (Bombay), the incidence is 0.9/100,000. 1 Approximately 95% of malignant tumors arising in the testes are germ cell tumors (GCT). 2 The cause of GCT in most cases is unknown. Cryptorchidism, familial predisposition, GCT in contralateral testis, gonadal dysgenesis and androgen in sensitivity syndrome and male infertility are associated with elevated risk of testis cancer. 2 Most of the established risk factors are related to early life events, including cryptorchidism, carcinoma in situ and in utero exposure to estrogens. Occupational, lifestyle, socio-economic and other risk factors have demonstrated mixed associations with testicular cancer.
Most of the GCT in adults appear to arise from the malignant transformation of primordial germ cells (PGCS) or gonocytes. Continuous proliferation of such cells within the seminiferous tubules heals the lesions that is termed intratubular germ cell neoplasia-unclassified type (ITGCNU) or carcinoma in situ (CIS). 2, 3 There is pivotal role of ITGCNU and seminoma in the development of various germ cell tumor types although alternative pathways excluded. The cells of ITGCNU are identical to seminoma cells. ITGCNU is found in almost all cases where residual seminiferous tubule are identified around an invasive GCT. It is also present in 5.8% cases of cryptorchidism and upto 5% of testis contralateral to an invasive GCT and also frequently in dysgenetic gonads. About 50% of patients with ITGCNU on biopsy will develop invasive GCT within 5 years and ultimately in almost all patients ITGCNU will progress to invasive tumors. Rarely in cases with metastatic GCT, ITGCNU may be found in the testis in association with a scar with or without calcification and without any recognized invasive tumor. Such cases are believed to represent burnt out GCT (regression of primary tumor). ITGCNU cells share a number of markers with the pluripotent primordial germ cell/gonadocytes, including placental alkaline phosphatase (CDLAD) and (KIT and OCT 3). 3 Numerous schemes for classifying GCT have been proposed on the basis of the tumors presumed histiogenesis or their predominant morphology, the classification Dixon and Moore 4 dominated for sometime. Historically urologists and oncologists have categorically rejected the use of fine needle aspiration (FNA) testis for the investigation of patients with presumed testicular neoplasms due to their fear that FNA testis would lead to tumor implantation within the scrotum and there by increased risk of inguinal node metastasis. Since majority of testicular tumors are malignant, FNA testis does not have a recognized and accepted role in establishing the diagnosis of testicular tumor FNA is helpful only for detection GCT of testis at metastatic or cryptorchid site.
The currently recommended staging system for testicular tumor is the AJCC-TNM staging. Testis is the only organ system to date where tumor marker levels are used, as important prognostic factor. [1] [2] [3] Serum tumor marker such as the beta subunit of human chorionic gonadotropin (beta-hCG), alpha fetoprotein (AFP) and lactate dehydrogenase (LDH) have an important role in the management of patients with testicular cancer, contributing to diagnosis, staging and risk assessment, evaluation of response to therapy. Early detection of LDH is recommended for patients with metastatic disease. 2 High inguinal orchiectomy is the standard initial treatment for suspected testicular tumor. Appropriate integration of surgery, chemotherapy and radiation therapy in treatment has lead to high cure rates. The introduction of cisplastin-based chemotherapy has revolutionized the management of testicular tumors, with considerable improvement in response rates and excellent outcome reported even in presence of metastatic disease.
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MATERIALS AND METHODS
All consecutive cases of testicular tumors diagnosed in the Department of Pathology at Wanless Hospital Miraj for five years were included in this study. Relevant clinical details such as age, clinical presentation and side of involvement of the testis were also recorded from the hospital records.
We have omitted the tumor like lesions of testis, paratesticular tumors and tumors of testicular adnexae in this study. Ten percent formalin was used as preservative and fixative for all specimens. The gross examination of the specimens was performed and adequate representative sections were obtained according to the guidelines provided by Rosai.
Paraffin-embedded sections were stained routinely with haematoxylin and eosin. Special stains like PAS, reticulin, etc., were used in selected cases.
Here an attempt is made to classify the tumors according to the histopathological typing of the testicular tumors published by WHO 2004. Incidence of various tumors encountered in our study is shown in (Table 1) . The age range of testicular tumor in this series was very wide (Table 2) , varied from youngest 2 years to oldest 80 years. The age distribution of different tumors was quite peculiar, the germ cell tumors were seen most commonly in the age range of 20 to 49 years. Seminoma was seen most commonly in the age range of 30 to 39 years. Embryonal carcinoma was common in age range 20 to 29 years. Yolk sac tumors was seen in childhood most commonly between 0 to 9 years. Teratocarcinoma was seen commonly in 20 to 29 years of age. No case of germ cell tumors of more than one histological type was seen in childhood or older age group. Lymphoid tumors were seen in old age more commonly than young ones. Patient presented clinically with history of scrotal swelling (94.6%), pain in abdomen, history of trauma or abdominal swelling as shown in (Table 3) .
DISCUSSION
Testicular tumors have fascinated the pathologists and clinicians alike since initial description over a century ago. The incidence of germ cell tumor of testis has shown a worldwide progressive increase in the 20th century. The incidence of testicular tumors as recorded in literature JMEDS varies from 0.5 to 2.73% of all malignant tumors in males and 13.04 to 23.4% of male uro-genital system tumors. In India, incidence is low i.e., 15.92%. 12, 13 Mortality rates for testicular cancer are very low, with the 5-year survival rate increasing from about 63% to more than 90% during the last 30 years. 12,13 Testicular tumors are rare, yet they constitute the fourth common cause of death. In our study testicular tumor accounted for 0.16% of all surgical specimens and 63.5% of all testicular lesions. Among the total 59 cases of testicular tumors, 53 (89.8%) were germ cell tumors (GCT) and 6 (10.2%) were cases of lymphoid and haemopoietic tumors.
Average age was found to be 24.7 years which was in concordance with the findingsof Fischer et al.
14 who found 33.3 years as the average age. We found maximum number of cases in age range 20 to 39 years (15 cases), followed by 13 cases in age range 40 to 49 years. our findings were in concordance with the findings of various other authors The peculiar distribution of different types of testicular tumors in particular age group in this study is similar to Mostofi and Price. 6 In the present study, 29 cases involved right testis and 27 cases involved left testis. Slight right side preponderance is also noted in other series, Mostofi and Price. 6 Gupta et al. 15 and Gupta et al. 16 and Chandanwale et al. 13 Embryonal carcinoma which involved left testis predominately. However, bilateral involvement was not observed. Scrotal swelling was the commonest mode of presentation seen in 84.6% patients, leaving four cases of maldescended testis . The duration of symptoms varied from 1 months to 15 years. In the study of Chandanwale et al. 13 duration was varied from 6 months to 10 years.
Secondary hydrocele was observed in Chandanwale et al. 13 (12%). Gupta et al. 15 (8.8%) cases We did not come across cases of testicular tumors with secondary hydrocele. History of pain in the present study was noted in only 10 patients (16.9%). Gupta et al. 15 got history of pain in 23.5% of patients, whereas Tan et al. 13 found associated pain in 22.6% of cases. History of trauma was available in seven (11.8%) patients. Gupta et al. 15 noted history of trauma in 7 out of 125 cases (5.60%) whereas, Deotra et al. 17 found history of trauma in 4% patients. Our findings were in concordance with them.
In present study we found associated lymphadenopathy in three cases (5.1%). The patients had inguinal, omental and mesenteric lymphadenopathy (n = 1 each). Only omental lymph node showed microscopic evidence of metastasis in a pure case of seminoma. While others showed reactive changes. Mostofi and Davis Jr. 18 had noticed metastasis in 25% cases at the time of firstexamination. Gynaecomastia was not seen in any of our cases. Mostofi and Davis Jr. 18 have noticed gynaecomastia in 2.10% cases. None of our case had presented with gynecomastia, infertility or gonadal dysgenesis or male pseudohermaphoridism which is an uncommon mode of presentation. In our study. four cases (6.8%) of patients had cryptorchidism. The percentage of incidence of tumors with maldescended testis varies from 3.6 to 10.7% (Table 4) incidence of testicular tumor in our series is comparable to Moghe et al. 19 In our series seminoma is the commonest tumor involving cryptorchid testis' (3 out of 4 cases). Of the four cases of cryptorchid testis three cases are intra abdominal and one case is of undescended testis corrected by orchiopexy risk of development of tumors in abdominal testis is 4 times more than inguinal testis as described by Dixon and Moore, 9 Collins and Pugh 21 Gupta, 15 and Deotra. 17 The comparison of frequency of individual testicular tumors with other workers study is depticted in (Table 5 ).
In GCT of one histological type, seminoma was commonest, it is constituted 32.2% of all GCT of one histological type and 55.6% all GCT of testis and 38% all testicular tumors. Percentage of seminoma in other series ranged from 27.78 to 56.5%. Our findings are slightly less than other workers whereas Gupta et al. 16 (27.2%) who have got even lower percentage. The average age of our series 39.2 years was comparable with other workers which was around 40 years. 13 The involvement of cryptorchid testis was seen in 3 out of 19 cases of seminoma (15.79%), all with abdominal testis. Metastasis to omental lymph node is seen in one case out of 19 cases of seminomas which histologically showed pure seminoma. Mostofi, and Price 6 observed metastasis in 10%. According to them pure seminoma metastasises as pure seminoma in 65% while as embryonal carcinoma and teratoma in 26% and 4% cases respectively. Gupta et al. 16 also noted one case of syncytiotrophoblastic giant cells in their study of 25 semi-nomas. The gross and microscopic findings of seminoma (Fig. 1 ) in the present study are similar to those described by others 6,13,15,16 the interstitial diffuse growth pattern is seen in all cases. None of the cases shows intratubular growth pattern. The interstitial growth is more common than intratubular growth in seminoma.
6 Lymphocytic infiltration of stroma is described by all workers except Damjanov 22 who have reported a case of seminoma devoid of lymphoid infiltrate. Granulomatous reaction is noted in 2 out of 19 cases i.e., (10.5%) Collin and Pugh et al. 21 have noted granulomatous rection in 40% cases which was extensive in 16% cases. Areas of tumor necrosis was seen in two cases of seminoma in this study. These are usually incospicuous but in large tumors they are extensive. The involvement of proximal surgical margin and epididymis is seen in two cases (10.5%). Mostofi and Price 6 have described extensive infiltration beyond capsule to scrotal skin, epididymis and spermatic cord in 8% cases. Only one case out of 19 cases of seminoma, i.e., 5.2% anaplastic features and 3 > or = mitosis per high power field. The same tumor showed syncytiotrophoblastic giant cells. (Fig. 2 ) Second commonest tumor of GCT category was embryonal carcinoma (Fig. 3) constituting 5% of all testicular tumors, and, 43.4% of GCT, 14.7% GCT of one histoligical type and 94.7% of GCT more than one histological type .the incidence of this tumor in various series showed wide range 4.2 to 37% of GCT [13] [14] [15] [16] 21 This is due to different interpretation of this term by various authors and inclusion of yolk sac tumor in adult embryonal carcinoma. Different followers of Collin and Pugh classification who do not use term embryonal carcinoma actually give higher incidence of this tumor as it includes teratocarcinoma such as, Moghe et al. 19 (36.4%) our findings are slightaly lower than other workers. The age range in our study is from 21 to 40 years with average age of 28 years. The age range in study of Gupta et al. 16 is comparable with this. Left side is involved more commonly than right side (4:1) in our study. The incidence of embryonal carcinoma as a part of mixed germ cell tumors was 94.7%, out of 19 cases 18 cases showed embryonal carcinoma as one of component. This high incidence is because of better sampling of orchidectomy specimen. The third commonest tumor was teratoma constituting 6.8% of all testicular tumors, 11.7% of GCT of one histological type. The incidence of teratoma reported a lower incidence varying from 1.3 to 24.45%. histologically all cases were of mature teratoma (Fig. 4) in our study. No case of immature teratoma and teratoma with malignant transformation was noted in our stutdy as the occurance of which is very veryrare. The age of our patient is 6 years, 12 years, 13 years, and 31 years is comparable to its common occurance in 1st to 3rd decade as described by Mostofi and Price 6 and Aggarwal et al. 23 reported 48%
teratoma in prepubertal males. Yolk sac tumor (Fig. 5) was found in 5.15% of all testicular tumors and 5.7% of all GCT and was a component of 15.59% GCT more than one histological and 8.85% as pure yolk sac tumor. The incidence reported varied from 4 to 13.37% Age range in our study was 2 to 18 years. Aggarwal et al. 23 have reported this tumor in 11 years
old. There was clinical evidence of spread to mesentric lymph node in one case. Choriocarcinoma (Fig. 6 ) was seen only in one case out of 59 tumors and constituted 1.7%. It was component of mixed germ cell tumor in two cases out of 19 cases of mixed germ cell tumor Collin and Pugh et al. 21 reported none among 1050 cases while in american testicular tumor registry 18 cases of pure choriocarcinoma were listed in 6000 testicular tumors. The incidence noted by Miller and Seljel 20 was 1.6%. Gupta et al. 15 0.8%, and Gupta et al. 16 2.2%. Age of the case of pure choriocarcinoma was 25-year and is comparable to its occurance in second and third decades as described by Mostofi and Price. 6 and Shivade et al. 24 Two cases of spermatocytic seminoma (Fig. 7) constitute 3.4% of 59 testicular tumors and 9.5% of 21 seminomas. Incidence varied between 1% to 9.35 to the age was 32 years and 50 years in these two cases with average age of 41 years. It occurs most commonly after the age of 50 years. Bergner et al. 25 reported bilateral seminoma in a 30 year old patient. There was no clinical evidence of metastasis in our cases which is very very rare event in case of spermatocytic seminoma. Schoberg et al. 26 have reported a case of metastasis of spermatocytic seminoma in axillary lymphnode. Bilateral involvement is more common in this type than in classical seminoma.No case of spermatocytic seminoma in cryptrorchid testis is reported so far including our study.
Our study showed 32.2% of GCT of more than one histological type, the wide range of variation of this categories is seen in different studies 62.2% Mostofi and Price. 6 and 4.4% Gupta et al. 16 except for spermatocytic seminoma, all other types may occur in combination, The incidence of germ cell tumors with more than one histological type is more because better sampling was done.
The most common combination encountered in this study was of teratoma and embryonal carcinoma (teratocarcinoma) (Fig. 8) . Teratocarcinoma was also seen associated with yolk sac tumor (n = 2) or seminoma (n = 2) or choriocarcinoma (n = 1) The teratocarcinoma was the commonest combination in our study, i.e., 8 out of 19 tumors (13.4%). This incidence is comparable to other workers. The age range varied from 17 to 52 years with average of 28.7 years. The age range of teratocarcinoma is 18 to 40 years with an average of 24.6 years. The maximum number of teratocarcinoma are seen in age range of 20 to 29 years similar findings are also noted by Gupta et al. 15 Mostofi and Price. 6 mentioned its common occurance in third decade but can occur earlier, in one of these cases, tumor involved crypt orchid test is which was initially corrected by orchiopexy. in one case teratoma was immature one while in another case of teratocarcinoma local spread to epididymis, spermatic cord and tunica was observed. 
